aPTT reagent sensitivity to progressive single FVIII deficiency or pan-deficiency of all factors
FVIII activity, % . | aPTT, s* . | All factor activity, % . | aPTT, s* . |
---|---|---|---|
100 | 28.6 | 100 | 29.4 |
90 | 28.6 | 90 | 30.1 |
80 | 29.6 | 80 | 31.9 |
70 | 30.7 | 70 | 33.9** |
60 | 31.5 | 60 | 37.4** |
50 | 32.5 | 50 | 43.0 |
40 | 34.3** | 40 | 51.9 |
30 | 36.1** | 30 | 69.9 |
20 | 39.1 | 20 | 108.0 |
15 | 40.5 | 15 | No clot |
10 | 44.5 | 10 | No clot |
5 | 49.6 | 5 | No clot |
1 | 61.1 | 1 | No clot |
0.001 | 79.6 | 0.001 | No clot |
FVIII activity, % . | aPTT, s* . | All factor activity, % . | aPTT, s* . |
---|---|---|---|
100 | 28.6 | 100 | 29.4 |
90 | 28.6 | 90 | 30.1 |
80 | 29.6 | 80 | 31.9 |
70 | 30.7 | 70 | 33.9** |
60 | 31.5 | 60 | 37.4** |
50 | 32.5 | 50 | 43.0 |
40 | 34.3** | 40 | 51.9 |
30 | 36.1** | 30 | 69.9 |
20 | 39.1 | 20 | 108.0 |
15 | 40.5 | 15 | No clot |
10 | 44.5 | 10 | No clot |
5 | 49.6 | 5 | No clot |
1 | 61.1 | 1 | No clot |
0.001 | 79.6 | 0.001 | No clot |